The Chilean tennis player Barbara Gatica was provisionally suspended by the International Tennis Integrity Agency (ITIA), after testing positive for boldenone in the tests he underwent at the Bogotá tournament last April.
Cat, 25 years old, She is ranked 211 in the world ranking of women’s tennis and 167 in doubles. The main racket of Chilean tennis had planned to play the preliminary phase of the Wimbledon tournament, but the suspension she met last May prevented her from taking part in the tournament.
The ITIA sent the player a pre-charge notice of an anti-doping rule violation on May 31 under Program Article 2.1 (presence of a Prohibited Substance in a Player’s Sample) and Article 2.2 (Use of a prohibited substance without a warrant) and confirmed the provisional suspension.
Gatica appealed the provisional suspension, which was denied by independent court president William Norris on June 17, 2022. The Chilean player provided a sample while competing in the Bogotá tournament in April 2022 and the test was found to contain boldenone, an unspecified banned substance listed on the 2022 World Anti-Doping Agency (WADA) Prohibited List, leading to a provisional suspension.
The trans-Andean company exercised its right to request a counter-analysis to see if it confirms the finding. While provisionally suspended, the player may not compete in or attend any tennis event sanctioned, organized or sanctioned by the governing bodies of the sport.